Eledon Pharmaceuticals, Inc.

ELDN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.3B · 33 employees
206
SEC Filings
$2.78
Close 2026-09-10
33
Employees

Business Summary

Eledon Pharmaceuticals is a clinical-stage biotechnology company developing tegoprubart, an IgG1 anti-CD40L antibody, to prevent transplant rejection in kidney and xenograft transplantation and to treat ALS. Tegoprubart targets the CD40L pathway to modulate immune response without lymphocyte depletion. The company acquired the IP for tegoprubart from Anelixis Therapeutics in September 2020 after abandoning its prior ENT-focused pipeline.

Latest Stock Quote

ELDN 2026-09-10 $2.78 O:$2.78 H:$2.805 L:$2.75 Vol:0.7M VWAP:$2.7825
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-116164EDGAR68K words
2025-03-202024-12-310000950170-25-042754EDGAR64K words
2024-03-282023-12-310000950170-24-038091EDGAR58K words
2023-03-302022-12-310000950170-23-011011EDGAR56K words
2022-03-242021-12-310001564590-22-011698EDGAR—
2021-03-312020-12-310001564590-21-016828EDGAR—
2020-03-172019-12-310001564590-20-011260EDGAR—
2019-03-282018-12-310001564590-19-009631EDGAR—
2018-04-022017-12-310001564590-18-007314EDGAR—
2017-03-032016-12-310001193125-17-069741EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001193125-26-349314EDGAR47K words
2025-11-142025-09-300001193125-25-283275EDGAR50K words
2025-08-142025-06-300001193125-25-180906EDGAR47K words
2025-05-142025-03-310000950170-25-071582EDGAR42K words
2024-11-122024-09-300000950170-24-125622EDGAR45K words
2024-08-192024-06-300000950170-24-098590EDGAR44K words
2024-05-152024-03-310000950170-24-060025EDGAR38K words
2023-11-092023-09-300000950170-23-062203EDGAR38K words
2023-08-102023-06-300000950170-23-041456EDGAR38K words
2023-05-112023-03-310000950170-23-021372EDGAR34K words
2022-11-142022-09-300000950170-22-025007EDGAR—
2022-08-112022-06-300000950170-22-016935EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001193125-26-349170EDGAR3K words
2026-03-190001193125-26-116154EDGAR3K words
2026-01-020001193125-26-000968EDGAR8K words
2025-11-140001193125-25-283294EDGAR3K words
2025-11-130001193125-25-278392EDGAR30K words
2025-11-070001193125-25-270286EDGAR2K words
2025-08-140001193125-25-180820EDGAR3K words
2025-08-060000950170-25-103975EDGAR2K words
2025-06-120000950170-25-085588EDGAR1K words
2025-05-140000950170-25-071370EDGAR2K words

206 total filings indexed. 174 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

solid-organ-transplantation-immunosuppression amyotrophic-lateral-sclerosis-(als)-treatment xenograft-transplantation islet-cell-transplantation cd40l/cd40-pathway-targeting abbreviated-ibox-composite-biomarker-scoring egfr-(estimated-glomerular-filtration-rate)-assessment

Company Identity

CIK0001404281
TickerELDN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.eledon.com
Listed2014-09-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: eb142b49849013d7a1291da6c6702f34a95b25a7f4d8ba9ec086a9aec8d6100c
parent: 07e7e9b5c0b9ec9bbcf9ef91be2a997ac3211b4cbca57f2670c0aa7a8a5e9417
content hash: 57580f210ee2023d999f28db749b5a0e9d1abb29b6ff712c9808e0a4ba182ca7
signed: 2026-09-29T19:01:06.905Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ELDN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ELDN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ELDN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.